Інститут Фармакології Та Токсикології Академії Медичних Наук України
Институт Фармакологии И Токсикологии Академии Медицинских Наук Украины
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Інститут Фармакології Та Токсикології Академії Медичних Наук України, Институт Фармакологии И Токсикологии Академии Медицинских Наук УкраиныfiledCriticalІнститут Фармакології Та Токсикології Академії Медичних Наук України
Priority to UA99021077ApriorityCriticalpatent/UA33470A/en
Publication of UA33470ApublicationCriticalpatent/UA33470A/en
Organic Low-Molecular-Weight Compounds And Preparation Thereof
(AREA)
Abstract
Contrary to Diazepam, Halotranc is 13 times less toxic and does not possess myorelaxation activity at anxiolytic doses. Therefore, the drug may be taken in daytime without the interference with the usual working activity of the patient.
UA99021077A1999-02-241999-02-24N-(n-acetylphenyl)-3,4,5-trimethoxybenzamide psychotropic drug of tranquilizing mode
UA33470A
(en)
Use of heterocyclic dihydropyrimidine derivatives for the preparation of pharmaceutical compositions with potassim channel activity, novel derivatives and pharmaceutical compositions containing them